阿斯利康 CEO 表示可能进军癌症疫苗研发
AstraZeneca May Enter Cancer Vaccine Development, CEO Says
AI 导读
阿斯利康 CEO Pascal Soriot 表示公司正考虑开发癌症疫苗，进入肿瘤学最热门的研究领域之一。他在马德里举行的欧洲肿瘤内科学会（ESMO）会议上告诉分析师，癌症疫苗已是公司内部多次讨论的话题。该技术的适用范围仍存在疑问。
正文 · 原文
October 27, 2026 at 4:44 PM UTC
AstraZeneca Plc is considering developing cancer vaccines and jumping into one of the hottest areas of oncology research where questions still remain over how broadly the technology will work.
Cancer vaccines have been a topic of very many internal discussions, Chief Executive Officer Pascal Soriot told analysts at the European Society For Medical Oncology’s conference in Madrid that wrapped up Tuesday.